臺灣健保癌症用藥事前審查實作指引
1.0.9 - ci-build

臺灣健保癌症用藥事前審查實作指引, published by 衛生福利部中央健康保險署. This guide is not an authorized publication; it is the continuous build for version 1.0.9 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/TWNHIFHIR/pas/ and changes regularly. See the Directory of published versions

ValueSet: NHI-健保事前審查-給付適應症值集

Official URL: https://nhicore.nhi.gov.tw/pas/ValueSet/nhi-apply-reason Version: 1.0.9
Active as of 2025-10-01 Computable Name: NHIApplyReason

NHI-健保事前審查-給付適應症值集

References

Logical Definition (CLD)

 

Expansion

Expansion performed internally based on codesystem NHI-健保事前審查-給付適應症 v1.0.9 (CodeSystem)

This value set contains 30 concepts

SystemCodeDisplay (en)JSONXML
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  C50P1早期乳癌-未發生腋下淋巴結轉移
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  C50P2早期乳癌-具腋下淋巴結轉移
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  C50R1轉移性乳癌
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  C16R1轉移性胃癌
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P001黑色素瘤
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P011非小細胞肺癌-SQ-2線
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P012非小細胞肺癌-Adeno-3線
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P013非小細胞肺癌第一線用藥(鱗狀、非鱗狀單用或非鱗併用)
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P014鱗狀非小細胞肺癌第一線用藥(併用化療)
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P015非小細胞肺癌鞏固治療(單用)
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P021小細胞肺癌(併用化療)
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P031典型何杰金氏淋巴瘤
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P041泌尿道上皮癌-2線
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P042泌尿道上皮癌-1線
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P043局部晚期或轉移性泌尿道上皮癌之維持療法
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P052胃癌-1線(併用化療)
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P061腎細胞癌
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P072晚期肝細胞癌-1線(併用標靶藥或免疫製劑藥)
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P081頭頸部鱗狀細胞癌第二線用藥
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P082頭頸部鱗狀細胞癌第一線用藥
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P091默克細胞癌
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P101食道鱗狀細胞癌
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P111惡性肋膜間皮瘤(ipilimumab併用nivolumab 120mg)
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P121膽道癌(併用化療)
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P131早期三陰性乳癌(併用化療)
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  P141大腸直腸癌
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  C83N2單獨使用於先前接受過至少一種化學或標靶治療方式無效或復發的被套細胞淋巴瘤成人病人
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  C88N3單獨使用於曾接受一種含單柱抗體及一種靜脈注射之alkylating agent之chemoimmunotherapy至少4療程以上後復發者的華氏巨球蛋白血症成年病人
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  C82N3與obinutuzumab併用，治療先前曾接受至少兩線(每線至少4個療程)全身性治療無效或復發的濾泡性淋巴瘤成人病人
https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason  C91N1單獨使用於慢性淋巴球白血病(CLL)成人病人

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code